| 1 |
34882402 | Discovery of Resorcinol-Based Polycyclic Structures as Tyrosinase Inhibitors for Treatment of Parkinson's Disease. | 2022 Jan 5 |
1 |
| 2 |
35456994 | Neuromelanin in Parkinson's Disease: Tyrosine Hydroxylase and Tyrosinase. | 2022 Apr 10 |
1 |
| 3 |
31334690 | 3D QSAR pharmacophore-based virtual screening for the identification of potential inhibitors of tyrosinase. | 2020 Jul |
1 |
| 4 |
30846695 | Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson's disease pathogenesis. | 2019 Mar 7 |
1 |
| 5 |
27640074 | Rare variants analysis of cutaneous malignant melanoma genes in Parkinson's disease. | 2016 Dec |
1 |
| 6 |
24917394 | In silico approach to inhibition of tyrosinase by ascorbic acid using molecular docking simulations. | 2014 |
1 |
| 7 |
15773923 | Tyrosinase exacerbates dopamine toxicity but is not genetically associated with Parkinson's disease. | 2005 Apr |
2 |
| 8 |
9792245 | Does tyrosinase exist in neuromelanin-pigmented neurons in the human substantia nigra? | 1998 Sep 11 |
1 |
| 9 |
1791980 | Cysteinyldopamine is not incorporated into neuromelanin. | 1991 Sep 30 |
1 |